Two decades of progress in heart failure care
Launched in 2005, the Get With The Guidelines - Heart Failure program was created to improve care for people hospitalized with heart failure, a condition that led to the death of about one in three patients within a year.
Today, more than 600 hospitals across the country are part of this effort to save lives. The program has helped close persistent care gaps through data-driven benchmarking, hospital toolkits, workshops, webinars and recognition programs, all aimed at accelerating adoption of evidence-based guideline-recommended therapies.
'The Get With The Guidelines program continues to be a cornerstone for improving heart failure care,' said Sabra Lewsey, M.D., MPH, volunteer chair of the American Heart Association's Heart Failure Systems of Care Committee and assistant professor of medicine at Johns Hopkins Medicine. 'Its impact on long-term survival demonstrates how quality improvement efforts can transform patient trajectories.'
The research manuscript, published in Circulation: Heart Failure, details how hospitals engaged in the program consistently outperform peers on heart failure process measures and patient outcomes, even after adjusting for variables like hospital size and geographic region. Notably, lower 30-day risk-standardized mortality rates at participating hospitals correlate with significantly better long-term survival for people with heart failure.
Insights from the program have helped shape modern understanding of the disease. Among other findings, Get With The Guidelines - Heart Failure data challenged longstanding assumptions that individuals with preserved left ventricular ejection fraction had more favorable prognoses — a discovery that spurred new lines of clinical investigation and public health strategy.
Despite measurable progress, challenges remain.
'Heart failure mortality is still too high, and far too few people receive the full benefit of available, evidence-based therapies,' said Gregg Fonarow, M.D., FAHA, longtime American Heart Association volunteer who helped to establish the program. Fonarow is also interim chief of the division of cardiology, director of the Ahmanson-UCLA Cardiomyopathy Center, co-director of the Preventative Cardiology Program and the Eliot Corday Chair in Cardiovascular Medicine and Science at the University of California, Los Angeles. 'This legacy quality improvement program improves the health care landscape for heart failure and serves as a guidepost for other cardiovascular and stroke conditions.'
The research authors note that Get With The Guidelines - Heart Failure registry remains a robust engine for future research, now with more than 170 peer-reviewed publications, nearly half of which appear in high-impact journals.
'This program is no longer a data repository but a nexus for outcomes sciences, data science, and implementation science, all of which now drive innovations in personalized care, inform national policy, and strengthen hospital systems across the country,' said Clyde W. Yancy, M.D., M.Sc., FAHA, past volunteer president of the American Heart Association (2009–2010) and chief of cardiology in the department of medicine at Northwestern University's Feinberg School of Medicine, in Chicago. Yancy was also instrumental is championing the development of the Get With The Guidelines program.
Additional Resources:
###
Statements and conclusions of studies published in the American Heart Association's scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association's overall financial information are available here.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.
For Media Inquiries: 214-706-1173
Michelle Rosenfeld: 214-706-1099; [email protected]
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
What Really Happens to Your Blood Pressure After You Eat a High-Salt Meal
What Really Happens to Your Blood Pressure After You Eat a High-Salt Meal originally appeared on Parade. If you have high blood pressure—or it runs in your family—you likely already know that you need to minimize the amount of salt in your diet. 'Sodium can cause vascular damage primarily through raising blood pressure,' says Dr. Michael Fattouh, MD, a cardiologist at Montefiore Fattouh explains that salt promotes fluid retention. 'You can think of this as having too much water in the pipes. This increases the pressure in your arteries, causing stress and damage to the vessels, while also causing your heart to work harder,' he says. 'High sodium causes you to retain fluid, which your kidneys need to dilute the sodium content. This increases your circulating blood volume, causing an increase in blood pressure, and we know high blood pressure over time is not good for you, adds Dr. Richard Kettelkamp, DO, a cardiologist at UnityPoint Health, St. Luke's Hospital. The detrimental impact too much sodium has on heart health is why the American Heart Association recommends capping sodium intake at 2,300 milligrams a day, or ideally 1,500 milligrams a you're wondering if one high-salt meal can really cause that much damage. Is enjoying a burger and fries every once in a while all that bad? To answer that question, it helps to know exactly what happens to blood pressure after eating a high-salt meal. 🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 How Eating a High-Salt Meal Impacts Blood Pressure Immediately Afterward What is considered a 'high salt' meal? Dr. Fattouh says that, generally, a high sodium meal contains 700 milligrams or more of sodium, but he says that even less than that can be high for certain people, such as those with high blood pressure.'High sodium meals are unfortunately not hard to come by. A cheeseburger and fries may have more than 1,000 milligrams of sodium,' he explains. Other examples of high-sodium foods include canned soup, frozen pizza, a sandwich with cold cuts and beef Dr. Kettelkamp adds that there is more sodium in many foods than people realize. 'It's not just table salt, it's what you cook with. Margarine and butter have quite a bit of sodium. There's a huge amount of sodium in soda. Canned vegetables and canned soups also have a lot of sodium and it's in a lot of prepared and processed foods too,' he says. So what happens immediately after eating a high-salt meal? According to Dr. Kettelkamp, within an hour, there is a rise in blood pressure, which is related to the regulation of sodium in the blood. 'Excessive sodium intake can lead to high blood pressure within a couple hours and in people who are more sensitive, some effects on your vessels are seen in as little as 30 minutes,' adds Dr. Dr. Michael Barry, MD, a cardiologist and partner with Clearwater Cardiovascular Consultants, says that after eating a high-sodium meal, fluid retention often occurs in the kidneys. This, he says, can eventually lead to increased blood pressure readings. Related: The Long-Term Impact of Eating High-Sodium Meals Dr. Kettelkamp says that while the average person isn't going to have a heart attack or stroke immediately after eating a high-sodium meal, regularly consuming excessive sodium does increase the likelihood of experiencing these detrimental cardiovascular events. 'Consistent high sodium intake can cause hypertensive urgency, or spikes in blood pressure, potentially leading to heart attacks and strokes. Usually, these patients already have high blood pressure, which is worsened by a high-sodium meal,' Dr. Barry adds. Related: Scientific research shows that regularly eating high-sodium foods is linked to kidney disease, strokes and heart disease. People who consume more than 4,000 milligrams of sodium a day increase their stroke risk between two and five times compared to those who keep sodium intake under 1,500 milligrams a day. If this is a sobering wake-up call, remember that there are many other delicious ways to flavor your food besides reaching for the salt shaker. Flavoring your food with spices and herbs is actually beneficial for heart health because they are full of antioxidants, which help lower blood pressure. And when it comes to store-bought foods, don't forget to do your label reading to see how much sodium is in each serving; it is often more than you think. By being mindful of your sodium intake, you will not only be keeping your blood pressure in check, you'll be supporting your entire cardiovascular system. It's advice worth taking to, well, heart. Up Next:Sources: Dr. Richard Kettelkamp, DO, cardiologist at UnityPoint Health, St. Luke's Hospital Dr. Michael Fattouh, MD, cardiologist at Montefiore Einstein Dr. Michael Barry, MD, cardiologist and partner with Clearwater Cardiovascular Consultants What Really Happens to Your Blood Pressure After You Eat a High-Salt Meal first appeared on Parade on Jul 16, 2025 This story was originally reported by Parade on Jul 16, 2025, where it first appeared.
Medscape
3 hours ago
- Medscape
FDA Widens Indication of Finerenone for Heart Failure Pts
The FDA has expanded the indications of finerenone to include patients with heart failure with a left ventricular ejection fraction (LVEF) of at least 40%. The expanded approval for finerenone, a nonsteroidal mineralocorticoid receptor antagonist developed by Bayer, comes on the strength of the phase 3 FINEARTS-HF trial, published last year in the New England Journal of Medicine. The study demonstrated that, alongside standard medical care, patients who received the drug achieved a 16% reduction in the risk of cardiovascular death and unplanned or urgent hospitalization due to heart failure. The benefit was driven by a reduction in worsening heart failure events; no significant effect was seen on cardiovascular death. The FDA initially approved finerenone in 2021 to reduce the risk for cardiovascular death, hospitalization for heart failure, nonfatal myocardial infarction, and kidney complications in adults with chronic kidney disease associated with type 2 diabetes. The latest decision expands treatment options for patients with heart failure with mildly reduced or preserved ejection fraction. '[A] large and growing group of patients with a poor prognosis,' said Scott Solomon, MD, a professor of medicine at Harvard Medical School and director of the Clinical Trials Outcomes Center at Mass General Brigham in Boston, in a statement. 'Based on the clinical efficacy we saw in the FINEARTS-HF study, finerenone can become a new pillar of comprehensive care,' added Solomon, who chaired the executive committee for the trial. Patients treated with finerenone had a higher risk for hyperkalemia. In an interview on Medscape at the time, Solomon said 'I think we can mitigate the risk for severe hyperkalemia with these drugs.' Approximately 3.7 million adults in the United States have heart failure with an LEVF of 40% or greater, according to 2024 figures from the Heart Failure Society of America. These patients face high rates of hospitalization, with each additional hospitalization associated with two-fold increased risk of death. 'Even with current treatments, 21% of patients with symptomatic heart failure escalate to hospitalization for heart failure or [cardiovascular] death, and 25% who experience hospitalization are readmitted due to heart failure within one year of discharge. Now, as a core pillar of treatment, KERENDIA can help patients reduce these risks,' Alanna Morris-Simon, MD, MSc, senior medical director of US Medical Affairs at Bayer, said in a statement. Finerenone is available in 10-, 20-, and 40-mg tablets. The drug is contraindicated for patients with hypersensitivity to the medication, adrenal insufficiency, or those taking strong CYP3A4 inhibitors. For more information about prescribing, click here.
Yahoo
6 hours ago
- Yahoo
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
(NewMediaWire) - July 16, 2025 - DALLAS The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 "Woman Changing the World Award" and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. "As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts," Ashton said. "And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association." As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. "As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery," Woo said. "The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all." "We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors," said Nancy Brown, CEO of the American Heart Association. "Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere." These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources Multimedia is available on the right column of release link. Learn more about the American Heart Association's 2025-26 volunteer and staff leadership. Follow AHA/ASA news on X @HeartNews ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
